Toggle Main Menu Toggle Search

Open Access padlockePrints

Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis

Lookup NU author(s): Professor John IsaacsORCiD, Dr Alice Lorenzi, Dr Gary Reynolds, Ross Farley, Helain Hinchcliffe-Hume, Dr Ismael Atchia

Downloads


Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).


Abstract

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ on behalf of EULAR.Objectives: This project aimed to determine whether cranial ischaemic complications at the presentation of giant cell arteritis (GCA) were associated with pre-existing cardiovascular (CV) risk factors, CV disease or genetic risk of CV-related traits. Methods: 1946 GCA patients with clinicodemographic data at GCA presentation were included. Associations between pre-existing CV-related traits (including Polygenic Risk Scores (PRS) for CV traits) and cranial ischaemic complications were tested. A model for cranial ischaemic complications was optimised using an elastic net approach. Positional gene mapping of associated PRS was performed to improve biological understanding. Results: In a sample of 1946 GCA patients (median age=71, 68.7% female), 17% had cranial ischaemic complications at presentation. In univariable analyses, 10 variables were associated with complications (likelihood-ratio test p≤0.05). In multivariable analysis, the two variables with the strongest effects, with or without PRS in the model, were anticoagulant therapy (adjusted OR (95% CI)=0.21 (0.05 to 0.62), p=4.95×10-3) and age (adjusted OR (95% CI)=1.60 (0.73 to 3.66), p=2.52×10-3, for ≥80 years versus <60 years). In sensitivity analyses omitting anticoagulant therapy from multivariable analysis, age and hypertension were associated with cranial ischaemic complications at presentation (hypertension: adjusted OR (95% CI)=1.35 (1.03 to 1.75), p=0.03). Positional gene mapping of an associated transient ischaemic attack PRS identified TEK, CD96 and MROH9 loci. Conclusion: Age and hypertension were risk factors for cranial ischaemic complications at GCA presentation, but in this dataset, anticoagulation appeared protective. Positional gene mapping suggested a role for immune and coagulation-related pathways in the pathogenesis of complications. Further studies are needed before implementation in clinical practice.


Publication metadata

Author(s): Chaddock NJM, Harden CJ, Sorensen L, Mathieson HR, Zulcinski M, Lawson CA, O'Sullivan E, Mollan SP, Martin J, Mackie SL, Iles MM, Morgan AW, Raashid LH, Martin S, Robinson JI, Morgan A, Mackie S, Wordsworth O, Whitwell I, Brock J, Douglas V, Hettiarachchi C, Bartholomew J, Jarrett S, Smithson G, Green M, Brown PC, Lawson C, Gordon E, Lane S, Francis R, Dasgupta B, Masunda B, Calver J, Patel Y, Thompson C, Gregory L, Levy S, Menon A, Thompson A, Dyche L, Martin M, Li C, Laxminarayan R, Wilcox L, de Guzman R, Isaacs J, Lorenzi A, Reynolds G, Farley R, Hinchcliffe-Hume H, Bejarano V, Hope S, Nandi P, Stockham L, Wilde C, Durrant D, Lloyd M, Ye C-S, Stevens R, Jilani A, Collins D, Pegler S, Rivett A, Price L, McHugh N, Skeoch S, O'Kane D, Kirkwood S, Vadivelu S, Pugmire S, Sultan S, Dooks E, Armstrong L, Sadik H, Nandagudi A, Abioye T, Ramos A, Gumus S, Sofat N, Harrison A, Seward A, Mollan S, Rahan R, Hawkins H, Emsley H, Bhargava A, Fleming V, Hare M, Raj S, George E, Allen N, Hunter K, O'Sullivan E, Bird G, Magliano M, Manzo K, Sanghera B, Hutchinson D, Hammonds F, Sharma P, Cooper R, McLintock G, Al-Saffar ZS, Green M, Elliott K, Neale T, Mallinson J, Lanyon P, Pradere M-J, Jordan N, Htut EP, Mushapaidzi T, Abercrombie D, Wright S, Rowlands J, Mukhtyar C, Kennedy J, Makkuni D, Wilhelmsen E, Kouroupis M, Bhagat S, John L, Hughes R, Walsh M, Buckley M, Mackay K, Camden-Woodley T, Redome J, Pearce K, Marianayagam T, Cruz C, Warner E, Atchia I, Walker C, Black K, Duffy S, Bukhari M, Fothergill L, Jefferey R, Toomey J, Dillon CR, Pothecary C, Green L, Toms T, Maher L, Davis D, Sayan A, Thankachen M, Abusalameh M, Record J, Khan A, Stafford S, Hussein A, Williams C, Fletcher A, Johson L, Burnett R, Moots R, Frankland H, Dale J, Moar K, Hollas C, Parker B, Ridings D, Eapen S, John S, Robson J, Guthrie LB, Fyfe R, Tait M, Marks J, Gunter E, Hernandez R, Bhat S, Johnston P, Khurshid M, Barclay C, Kapur D, Jeffrey H, Hughes A, Slack L, Thomas E, Royon A, Hall A, King J, Nyathi S, Morris V, Castelino M, Hawkins E, Tomson L, Singh A, Nunag A, O'Connor S, Rushby N, Hewitson N, O'Sunmboye K, Lewszuk A, Boyles L, Perry M, Williams E, Graver C, Defever E, Kamanth S, Kay D, Ogor J, Winter L, Horton S, Welch G, Hollinshead K, Peters J, Labao J, Dmello A, Dawson J, Graham D, De Lord D, Deery J, Hazelton T

Publication type: Article

Publication status: Published

Journal: Annals of the Rheumatic Diseases

Year: 2024

Pages: epub ahead of print

Online publication date: 03/10/2024

Acceptance date: 28/08/2024

Date deposited: 28/10/2024

ISSN (print): 0003-4967

ISSN (electronic): 1468-2060

Publisher: BMJ Publishing Group

URL: https://doi.org/10.1136/ard-2024-225515

DOI: 10.1136/ard-2024-225515

Data Access Statement: Data are available on reasonable request. Data access requests should be directed to the corresponding author. UK Biobank data may be accessed by completing an application at https://www.ukbiobank.ac.uk/. Generated PRS is available on request.

PubMed id: 39362697


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Leeds Cares
MRC
NIHR Leeds Biomedical Research Centre

Share